Criminal Antitrust Litigation Handbook Book

I thought this book was going to be more of a revelation, but two things got in the way. First, it's out of date--it was written before Medicare Part D was written into law, or the new healthcare law and attendant debates. While it must be satisfying to the author for her predictions to have been proven correct, for the 2011 reader, it just results in the urge to yell, "Yes, it will! No, they won't! They've already gotten to that point!" a great deal.

Second, the pharmaceutical companies have actually gotten worse, which makes some of her biggest revelations about R&D and marketing practices seem anticlimactic. It's probably also not in her favor that I consider myself pretty well educated on this subject, so there really wasn't anything in the book that I hadn't already heard somewhere else. Then again, maybe the reason I heard it is because it came out of media coverage of her book. In any case, it's a good starting place for someone who's a newcomer to this topic.